ANTX AN2 Therapeutics Inc

USD 1.44 0.00 ( 0.00%)
Icon

AN2 Therapeutics Inc (ANTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.44

0.00 (0.00%)

USD 0.04B

0.15M

USD 2.60(+80.56%)

N/A

Icon

ANTX

AN2 Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 1.44
0.00 ( 0.00%)

AN2 Therapeutics Inc (ANTX) Stock Forecast

Show ratings and price targets of :
USD 2.60
(+80.56%)

Based on the AN2 Therapeutics Inc stock forecast from 3 analysts, the average analyst target price for AN2 Therapeutics Inc is USD 2.60 over the next 12 months. AN2 Therapeutics Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of AN2 Therapeutics Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, AN2 Therapeutics Inc’s stock price was USD 1.44. AN2 Therapeutics Inc’s stock price has changed by +14.29% over the past week, -13.77% over the past month and -92.97% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...